We have provided evidence for a multifaceted antitumor-function of the Toll-like receptor 7 (TLR7) agonist imiquimod, which rapidly recruits plasmacytoid dendritic cells and possibly other immune cells into tumors by inducing the secretion of CCL2 by dermal cells. Imiquimod induces pDC maturation and their conversion into cytolytic killer cells, which are capable of eliminating tumors independently from the adaptive immune system.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525638 | PMC |
| http://dx.doi.org/10.4161/onci.22033 | DOI Listing |
Publication Analysis
Top Keywords
plasmacytoid dendritic
8
dendritic cells
8
cells
5
imiquimod licenses
4
licenses plasmacytoid
4
cells kill
4
kill tumors
4
tumors provided
4
provided evidence
4
evidence multifaceted
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!